2-(p-tolyl)propan-1-amine | 4395-75-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 2-(p-tolyl)propan-1-amine
• 英文别名: 2-(4-Methylphenyl)propan-1-amine
• CAS: 4395-75-9
• 化学式: C₁₀H₁₅N
• mdl: MFCD11590259
• 分子量: 149.236
• InChiKey: OSYBUIYEZRXUGS-UHFFFAOYSA-N

物化性质

• 沸点：
  240.2 °C
• 密度：
  0.9417 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-(对甲苯基)丙醛 在 ammonium acetate 、 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 生成 2-(p-tolyl)propan-1-amine
  参考文献：
  名称：

  Kinbara, Kazushi; Harada, Yoshiko; Saigo, Kazuhiko, Journal of the Chemical Society. Perkin Transactions 2 (2001), 2000, # 7, p. 1339 - 1347

  摘要：

  DOI：

文献信息

• Direct Access to Primary Amines from Alkenes by Selective Metal‐Free Hydroamination
  作者：Yi‐Dan Du、Bi‐Hong Chen、Wei Shu

  DOI：10.1002/anie.202016679

  日期：2021.4.26

  selective synthesis of primary amines from easily available precursors is attractive yet challenging. Herein, we report the rapid synthesis of primary amines from alkenes via metal‐free regioselective hydroamination at room temperature. Ammonium carbonate was used as ammonia surrogate for the first time, allowing for efficient conversion of terminal and internal alkenes into linear, α‐branched, and α‐tertiary

  由容易获得的前体直接和选择性合成伯胺是有吸引力的，但仍具有挑战性。在此，我们报道了室温下通过无金属的区域选择性加氢胺从烯烃快速合成伯胺的方法。碳酸铵首次用作氨替代物，可在温和条件下将末端和内部烯烃有效转化为线性，α支化和α叔伯胺。该方法提供了一种直接而有效的方法，可用于制药化学和其他领域特别感兴趣的各种先进的，高度官能化的伯胺。
• Fast Titanium‐Catalyzed Hydroaminomethylation of Alkenes and the Formal Conversion of Methylamine
  作者：Jens Bielefeld、Sven Doye

  DOI：10.1002/anie.202001111

  日期：2020.4.6

  The scientific interest in catalytic hydroaminoalkylation reactions of alkenes has vastly increased over the past decade, but these reactions have struggled to become a viable option for general laboratory or industrial use because of reaction times of several days. The titanium-based catalytic system introduced in this work not only reduces the reaction time by several orders of magnitude, into the

  在过去的十年中，人们对烯烃催化加氢氨基烷基化反应的科学兴趣大大增加，但由于反应时间长达数天，这些反应一直难以成为一般实验室或工业用途的可行选择。这项工作中引入的钛基催化系统不仅将反应时间缩短了几个数量级，达到几分钟的范围，而且该催化剂也被证明可以很容易地从普通起始材料中获得，成本约为 1 欧元每毫摩尔催化剂。我们还能够正式对甲胺进行 CH 活化，并通过胺的甲硅烷基保护和简单的水脱保护实现与多种烯烃的偶联。
• [EN] METHOD FOR PRODUCING AN OPTICALLY ACTIVE NITRO COMPOUND<br/>[FR] PROCEDE DE PRODUCTION D'UN COMPOSE NITRO OPTIQUEMENT ACTIF
  申请人：CARREIRA ERICK M

  公开号：WO2004103951A1

  公开（公告）日：2004-12-02

  An optically active nitro compound having two hydrogen atoms on its α-cabon atom and having β-asymmetric carbon atom can be produced by making α, β-unsaturated nitroolefin having a hydrogen atom on its α-cabon atom react with at least two organosilicon compounds having at lest one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex, or react with an organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.

  具有两个氢原子的α-碳原子和β-手性碳原子的光学活性硝基化合物可以通过使具有α-碳原子上的氢原子的α，β-不饱和硝基烯烃与至少两个分子中至少有一个硅-氢键的有机硅化合物在存在不对称铜配合物的情况下反应，或者在存在不对称铜配合物和水的情况下，使具有至少一个硅-氢键的有机硅化合物与α-碳原子上的氢原子反应来制备。
• Method for producing an optically active nitro compound
  申请人：Carreira M. Erick

  公开号：US20070037976A1

  公开（公告）日：2007-02-15

  An optically active nitro compound having two hydrogen atoms on its α-cabon atom and having β-asymmetric carbon atom can be produced by making α, β-unsaturated nitroolefin having a hydrogen atom on its α-cabon atom react with at least two organosilicon compounds having at lest one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex, or react with an organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.

  具有α-碳原子上两个氢原子和β-不对称碳原子的光学活性硝基化合物可以通过使具有α-碳原子上氢原子的α，β-不饱和硝基烯与至少两种分子中具有至少一个硅-氢键的有机硅化合物在不对称铜配合物存在下反应，或在不对称铜配合物和水存在下与具有至少一个硅-氢键的有机硅化合物反应而制得。
• NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE
  申请人：Wong Michael K.

  公开号：US20130012434A1

  公开（公告）日：2013-01-10

  The present invention relates to compounds of the general formula: wherein ring A, ring B, R1, R3, Z, L1, and L2 are selected independently of each other and are as defined herein, to compositions comprising the compounds, and to methods of using the compounds as glucagon receptor antagonists and for the treatment or prevention of type 2 diabetes and conditions related thereto.

  本发明涉及通式化合物：其中环A、环B、R1、R3、Z、L1和L2是彼此独立选择并如下所定义的，以及包含该化合物的组合物，以及使用该化合物作为胰高血糖素受体拮抗剂以及治疗或预防2型糖尿病及相关疾病的方法。